International Immunology, Vol. 13, No. 3, 321-327,
March 2001
© 2001 Japanese Society for Immunology
The non-classical MHC class I molecule Qa-1b inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes
1 Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3 Canada
2 Unité de Biologie Moléculaire du Gène, INSERM U277, Institute Pasteur, 75015 Paris, France
3 Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada
Correspondence to: F. Takei, Terry Fox Laboratory, British Columbia Cancer Research Centre, 601 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada
The CD94/NKG2A heterodimer is an inhibitory receptor expressed on a subset of mouse NK cells. CD94/NKG2A recognizes the non-classical MHC class I (class Ib) molecule Qa-1b and inhibits NK cytotoxicity. Qa-1b presents a peptide derived from the leader sequence of classical MHC class I molecules. Here, we examined the role of CD94/NKG2A in T cell-mediated cytotoxicity. Soluble tetrameric Qa-1b bound to almost all CD8+, but not CD4+, T cells. This binding seems to be mediated by CD8, because COS cells transfected with CD8 also bound Qa-1b tetramer. Therefore, the expression of CD94/NKG2 in T cells was further examined by single-cell RT-PCR. Most murine CD8+ T cells constitutively expressed CD94 and NKG2A transcripts, whereas they were not detected in CD4+ T cells. Co-expression of Qa-1b and Dk on target cells significantly inhibited cytotoxicity of Dk-specific cytotoxic T lymphocytes generated by mixed lymphocyte reaction, indicating that Qa-1b on antigen-presenting cells interacts with CD94/NKG2A on CD8 T cells and regulates classical MHC class I-restricted cytotoxic T cells. These results suggest a significant role of CD94/NKG2A as an inhibitory receptor on CD8+ T cells.
Keywords: cell-cell interactions, cytotoxic T lymphocyte, MHC rodent
Transmitting editor: J. Schrader
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Iizuka, T. Kaifu, A. Nakamura, M. Obinata, and T. Takai Establishment and Functional Characterization of Novel Natural Killer Cell Lines Derived from a Temperature-Sensitive SV40 Large T Antigen Transgenic Mouse J. Biochem., August 1, 2006; 140(2): 255 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Keino, S. Masli, S. Sasaki, J. W. Streilein, and J. Stein-Streilein CD8+ T Regulatory Cells Use a Novel Genetic Program that Includes CD103 to Suppress Th1 Immunity in Eye-Derived Tolerance. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1533 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Davies, S. Kalb, B. Liang, C. J. Aldrich, F. A. Lemonnier, H. Jiang, R. Cotter, and M. J. Soloski A Peptide from Heat Shock Protein 60 Is the Dominant Peptide Bound To Qa-1 in the Absence of the MHC Class Ia Leader Sequence Peptide Qdm J. Immunol., May 15, 2003; 170(10): 5027 - 5033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gunturi, R. E. Berg, and J. Forman Preferential Survival of CD8 T and NK Cells Expressing High Levels of CD94 J. Immunol., February 15, 2003; 170(4): 1737 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Meyers, A. Ryu, L. Monney, K. Nguyen, E. A. Greenfield, G. J. Freeman, and V. K. Kuchroo Cutting Edge: CD94/NKG2 Is Expressed on Th1 But Not Th2 Cells and Costimulates Th1 Effector Functions J. Immunol., November 15, 2002; 169(10): 5382 - 5386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kabat, F. Borrego, A. Brooks, and J. E. Coligan Role That Each NKG2A Immunoreceptor Tyrosine-Based Inhibitory Motif Plays in Mediating the Human CD94/NKG2A Inhibitory Signal J. Immunol., August 15, 2002; 169(4): 1948 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. McMahon, A. J. Zajac, A. M. Jamieson, L. Corral, G. E. Hammer, R. Ahmed, and D. H. Raulet Viral and Bacterial Infections Induce Expression of Multiple NK Cell Receptors in Responding CD8+ T Cells J. Immunol., August 1, 2002; 169(3): 1444 - 1452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Miller, M. Peters, A. E. Oran, G. W. Beresford, L. Harrington, J. M. Boss, and J. D. Altman CD94/NKG2 Expression Does Not Inhibit Cytotoxic Function of Lymphocytic Choriomeningitis Virus-Specific CD8+ T Cells J. Immunol., July 15, 2002; 169(2): 693 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Lian, M. Maeda, S. Lohwasser, M. Delcommenne, T. Nakano, R. E. Vance, D. H. Raulet, and F. Takei Orderly and Nonstochastic Acquisition of CD94/NKG2 Receptors by Developing NK Cells Derived from Embryonic Stem Cells In Vitro J. Immunol., May 15, 2002; 168(10): 4980 - 4987. [Abstract] [Full Text] [PDF]
|
|